Opioid antagonists: a review of their role in palliative care, focusing on use in opioid-related constipation.
about
Opioid-induced constipation: advances and clinical guidanceDevelopments in managing severe chronic pain: role of oxycodone-naloxone extended releaseOpioid-induced bowel dysfunction: prevalence, pathophysiology and burdenOpioid induced bowel disease: a twenty-first century physicians' dilemma. Considering pathophysiology and treatment strategiesEfficacy and tolerability balance of oxycodone/naloxone and tapentadol in chronic low back pain with a neuropathic component: a blinded end point analysis of randomly selected routine data from 12-week prospective open-label observations.Combined oral prolonged-release oxycodone and naloxone in opioid-induced bowel dysfunction: review of efficacy and safety data in the treatment of patients experiencing chronic pain.Efficacy and safety of combined prolonged-release oxycodone and naloxone in the management of moderate/severe chronic non-malignant pain: results of a prospectively designed pooled analysis of two randomised, double-blind clinical trials.Management of gastrointestinal symptoms in advanced cancer patients: the rapid learning cancer clinic model.Methylnaltrexone: the evidence for its use in the management of opioid-induced constipation.Long-term efficacy and safety of combined prolonged-release oxycodone and naloxone in the management of non-cancer chronic pain.Utilization of methylnaltrexone (relistor) for opioid-induced constipation in an oncology hospital.Efficacy and tolerability of low-dose oral prolonged-release oxycodone/naloxone for chronic nononcological pain in older patientsQuality of life and healthcare resource in patients receiving opioids for chronic pain: a review of the place of oxycodone/naloxoneLong-term safety and efficacy of oxycodone/naloxone prolonged-release tablets in patients with moderate-to-severe chronic cancer pain.Anticipating and treating opioid-associated adverse effects.A randomized, double-blind, active-controlled, double-dummy, parallel-group study to determine the safety and efficacy of oxycodone/naloxone prolonged-release tablets in patients with moderate/severe, chronic cancer pain.Pharmacologic treatment of constipation in cancer patients.Alvimopan for the management of postoperative ileus.Constipation and palliative care - where are we now?Methylnaltrexone mechanisms of action and effects on opioid bowel dysfunction and other opioid adverse effects.A review of methylnaltrexone, a peripheral opioid receptor antagonist, and its role in opioid-induced constipation.Opioid-Induced Constipation among a Convenience Sample of Patients with Cancer Pain.Patient assessment of a novel therapeutic approach for the treatment of severe, chronic pain.Peace, Equanimity, and Acceptance in the Cancer Experience (PEACE): validation of a scale to assess acceptance and struggle with terminal illnessEffectiveness of two opioid antagonists in treating opioid-induced constipation.Pain therapy with oxycodone/naloxone prolonged-release combination: case report.Methylnaltrexone: a novel approach for the management of opioid-induced constipation in patients with advanced illness.Management of opioid-induced constipation in cancer patients: focus on methylnaltrexone.Cancer pain management: what's new?Perioperative management of delirium and dementia in the geriatric surgical patient.Naloxegol: A Novel Therapy in the Management of Opioid-Induced Constipation.Reversal agents in anaesthesia and critical care.Opioids in Gastroenterology: Treating Adverse Effects and Creating Therapeutic Benefits.Opioids in the treatment of restless legs syndrome: pharmacological and clinical aspects.Methylnaltrexone: a subcutaneous treatment for opioid-induced constipation in palliative care patients.New Formulation of Sustained Release Naloxone Can Reverse Opioid Induced Constipation Without Compromising the Desired Opioid Effects.Impact of constipation on opioid use patterns, health care resource utilization, and costs in cancer patients on opioid therapy.Laxatives Do Not Improve Symptoms of Opioid-Induced Constipation: Results of a Patient Survey.Standardized treatment of Chinese medicine decoction for cancer pain patients with opioid-induced constipation: a multi-center prospective randomized controlled study.Tolerability, gut effects, and pharmacokinetics of methylnaltrexone following repeated intravenous administration in humans.
P2860
Q26765571-EA79334A-A52E-4912-A2B5-AE8383E701F9Q26801140-4893D9B7-1937-40AF-8836-5A3DB3E60FD4Q28209970-D423CF5C-A035-4989-B749-6FDDC732FAB7Q28294194-D1AFDA4A-049D-4D9F-8E64-24FED0CC5FE8Q31144449-4F46787B-6FF7-4D47-8CC2-8E168432CB69Q33520508-EF17D995-DD87-49C9-976E-DCEA3335F0E2Q33709851-F778DEE4-6A91-4736-ABCA-B0B7B3344979Q33854239-A123EC01-9E87-4813-9FB8-7762B78134B0Q33973870-E69AE6A1-E8C0-49A6-80D8-F25D5F41B4BCQ34167814-21D9374F-C7D0-4334-B6E4-61867DCF21D7Q34614438-67C11710-3C5F-4BDC-B192-24A86E88EDCAQ34787421-0F8837DC-A350-4DA3-8777-11685119469BQ34798408-59032093-520A-4D17-8B28-069F51DB6801Q35028902-9C846082-0151-4789-AA39-46BD5ECFD15FQ35194392-ADB9E56B-2D40-4F31-A663-1E7DFB78694BQ35664979-ADEC1804-4A3A-4C74-AAF6-ECFAABA75F01Q35778565-87E9196E-17B2-475D-AF4F-766BEF4FFED5Q36217219-F66660F8-DB1C-4523-A92C-D660A95479DFQ36758292-30DE1706-5F0B-4CA0-BA0A-FAFE30AF1C2AQ36823204-8D50F6EE-8746-474F-914E-34A39D051E68Q36852958-9094C0E2-C0FD-4956-98CF-91744B289D8AQ36978683-8352F7EB-6788-4B9A-BF9A-E4CFB9CCD266Q37134310-711AB5AD-1717-429E-830D-E54FF645B33AQ37257432-D209504A-9944-456E-9943-353F59085F16Q37601903-B7BC1559-1350-4B3B-9D5B-C5C31B96F9A7Q37601924-FF727C24-0D8E-4256-A784-83EA84AB1523Q37611847-2F26C70E-3240-4BD1-B605-E02D62885A1AQ37993108-8D5183D7-056B-4198-BA23-3B8049E6B351Q38086150-84264F7F-5717-4715-9751-8531E271E142Q38131375-AE1CFC4C-A156-4497-9682-7F492C509A15Q38543507-F0C82EDF-F7A5-4DF2-A089-A1E4DC39C5F8Q38661905-4978ABAB-4E99-4578-A57D-F282E0CC0841Q38772298-1E88E617-C014-4AA9-ACA7-CF871086C099Q38867027-1C265E9C-3718-4029-BB66-72EB85E1A67EQ43191518-D446AEE5-FB66-4CA7-9DFC-2A89D4AFC21AQ43335045-5D1C3CAE-1B67-4354-B457-5E1070759DE4Q43779475-15F5D147-1502-4EB1-987E-6DF58A08BD80Q44344292-2A7A98E8-65E4-4375-AEE6-D7604F9386D3Q44345622-B2AD5C83-15B6-4CAE-9E67-216CDD19AC1DQ46438870-B3869A5D-542A-4B42-AD35-9EEA895CD636
P2860
Opioid antagonists: a review of their role in palliative care, focusing on use in opioid-related constipation.
description
2002 nî lūn-bûn
@nan
2002 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Opioid antagonists: a review o ...... n opioid-related constipation.
@ast
Opioid antagonists: a review o ...... n opioid-related constipation.
@en
Opioid antagonists: a review o ...... n opioid-related constipation.
@nl
type
label
Opioid antagonists: a review o ...... n opioid-related constipation.
@ast
Opioid antagonists: a review o ...... n opioid-related constipation.
@en
Opioid antagonists: a review o ...... n opioid-related constipation.
@nl
prefLabel
Opioid antagonists: a review o ...... n opioid-related constipation.
@ast
Opioid antagonists: a review o ...... n opioid-related constipation.
@en
Opioid antagonists: a review o ...... n opioid-related constipation.
@nl
P1476
Opioid antagonists: a review o ...... n opioid-related constipation.
@en
P2093
J Andrew Billings
Youn Seon Choi
P356
10.1016/S0885-3924(02)00424-4
P577
2002-07-01T00:00:00Z